What if a molecule made by a bacterium in the gut could help the body burn more of the fat most closely linked to metabolic disease? New research from Duke University School of Medicine points to a ...

Duke researchers are leading a phase I clinical trial to evaluate a new experimental treatment for glioblastoma, one of the most aggressive and deadly forms of brain cancer. The drug is a type of ...

David Tuveson, MD, PhD, will join Duke Health as executive director of the Duke Cancer Institute (DCI), effective October 31, 2026. Tuveson, a preeminent cancer biologist, is currently the Roy J.

E-cigarettes are often promoted as a better way to quit smoking than nicotine patches or gum. But Duke University School of Medicine researchers say a key piece of the story is often missing: how many ...

Stroke, ALS, and other neurodegenerative and acute brain disorders can rob people of the ability to speak. Brain-to-computer interfaces can restore it by translating brain activity into ...

Heidi T. Jacobe, MD, MSCS, will join Duke Health as chair of the Department of Dermatology, effective December 1, 2026. A nationally recognized leader in the field of dermatology, Jacobe is currently ...

Researchers at Duke University School of Medicine are investigating how to keep opioids' pain-relieving benefits while reducing their addictive potential. In a study published in Nature, they report a ...

Researchers at Duke University School of Medicine have developed an artificial intelligence framework that can redesign proteins on a scale previously seen only in natural evolution. The tool can ...

A sharp drop in credit score, missed loan payments, and repossession may be warning signs for suicide risk, according to new research. A JAMA Network Open study found that veterans experiencing major ...

The popularity of GLP-1 drugs has created a new generation of body contouring patients and a new set of challenges for plastic surgeons. New research from Duke University School of Medicine suggests ...

The weight loss revolution has a surprising new star: glucagon, a hormone that has lived in insulin’s shadow. For nearly a century, glucagon occupied a familiar role in biology textbooks. Insulin ...

The Duke University School of Medicine proudly announces the recipients of the 2026 Faculty Awards, honoring outstanding contributions in teaching, research, clinical care, professionalism, and ...